Signup Crypto ETF Stocks News

Serve Robotics to Hold Annual Meeting of Stockholders on June 12, 2025

SAN FRANCISCO, May 30, 2025 ( GLOBE NEWSWIRE ) -- Serve Robotics ( the "Company" or "Serve" ) ( Nasdaq: SERV ) , a leading autonomous sidewalk delivery company, will hold its Annual Meeting of Stockholders ( "Annual Meeting" ) virtually on Thursday, June 12, 2025 at noon PDT.

Source: www.globenewswire.com
May 30, 2025 | 11:30:00
Category: News

Serve Robotics to Hold Annual Meeting of Stockholders on June 12, 2025 - Serve Robotics ( NASDAQ:SERV )

SAN FRANCISCO, May 30, 2025 ( GLOBE NEWSWIRE ) -- Serve Robotics ( the "Company" or "Serve" ) SERV, a leading autonomous sidewalk delivery company, will hold its Annual Meeting of Stockholders ( "Annual Meeting" ) virtually on Thursday, June 12, 2025 at noon PDT.

Source: www.benzinga.com
May 30, 2025 | 11:30:00
Category: News

Nexxen Announces Transition to Reduced $50 Million Revolving Credit Facility

NEW YORK, May 30, 2025 ( GLOBE NEWSWIRE ) -- Nexxen International Ltd. ( NASDAQ: NEXN ) ( "Nexxen" or the "Company" ) , a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that it has successfully completed an amendment to its existing ...

Source: www.globenewswire.com
May 30, 2025 | 11:30:00
Category: News

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - TG Therapeutics ( NASDAQ:TGTX )

NEW YORK, May 30, 2025 ( GLOBE NEWSWIRE ) -- TG Therapeutics, Inc. TGTX, today announced the presentations of data highlighting BRIUMVI® ( ublituximab-xiiy ) in patients with relapsing forms of multiple sclerosis ( RMS ) , at the 2025 Consortium of Multiple Sclerosis Centers ( CMSC ) annual ...

Source: www.benzinga.com
May 30, 2025 | 11:30:00
Category: General

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers - Adaptive Biotechnologies ( NASDAQ:ADPT )

SEATTLE, May 30, 2025 ( GLOBE NEWSWIRE ) -- Adaptive Biotechnologies Corporation ADPT, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced that its next-generation ...

Source: www.benzinga.com
May 30, 2025 | 11:30:00
Category: News

3 American Growth Giants to Invest in for the Long Haul

Many of the best growth stocks in the world are based out of the U.S. This is the land of both opportunity and innovation. Warren Buffett has always been bullish on betting on the U.S. because he's a big believer in American business.If you want to follow suit and invest in some of the country's ...

Source: www.fool.com
May 30, 2025 | 11:30:00
Category: News

Sparton Announces Closing of Sale of a 25 Per Cent Interest in Bruell Gold Project Claims, Quebec

TORONTO, May 30, 2025 ( GLOBE NEWSWIRE ) -- Sparton Resources Inc. ( SRI: TSX-V ) ( the "Company" ) is pleased to announce that the Company and Eldorado Gold Corporation ( "Eldorado" ) have closed an agreement, effective May 29, 2025, whereunder Eldorado acquired the Company's remaining 25% ...

Source: www.globenewswire.com
May 30, 2025 | 11:30:00
Category: News

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

30 scientific abstracts will be presented using clonoSEQ for MRD assessment across multiple types of blood cancers 30 scientific abstracts will be presented using clonoSEQ for MRD assessment across multiple types of blood cancers ...

Source: www.globenewswire.com
May 30, 2025 | 11:30:00
Category: News

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting

NEW YORK, May 30, 2025 ( GLOBE NEWSWIRE ) -- TG Therapeutics, Inc. ( NASDAQ: TGTX ) , today announced the presentations of data highlighting BRIUMVI® ( ublituximab-xiiy ) in patients with relapsing forms of multiple sclerosis ( RMS ) , at the 2025 Consortium of Multiple Sclerosis Centers ( CMSC ...

Source: www.globenewswire.com
May 30, 2025 | 11:30:00
Category: News

Nexxen Announces Transition to Reduced $50 Million Revolving Credit Facility - Nexxen International ( NASDAQ:NEXN )

NEW YORK, May 30, 2025 ( GLOBE NEWSWIRE ) -- Nexxen International Ltd. NEXN ( "Nexxen" or the "Company" ) , a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that it has successfully completed an amendment to its existing revolving ...

Source: www.benzinga.com
May 30, 2025 | 11:30:00
Category: News

© Natavest 2025 - 2026